Table 1.
Non-obese (n = 27) | Obese (n = 9) | P-valuea | ||
---|---|---|---|---|
Mean ± s.e.m. | Crude | Race adjusted | ||
z_BMI | 0.97 ± 0.11 | 2.37 ± 0.087 | 0.0001 | 0.0001 |
Body fat (%) | 7.86 ± 0.53 | 18.17 ± 1.88 | 0.0004 | 0.0009 |
HOMA-IR (mmol µl−2) | 0.61 ± 0.1 | 1.36 ± 0.37 | 0.0832 | 0.2395 |
VAT (cm2) | 13.122 ± 1.218 | 19.64601 ± 2.203 | 0.0222 | 0.0331 |
SAT (cm2) | 94.377 ± 10.850 | 281.7344 ± 33.644 | 0.0004 | 0.0001 |
IHL (%) | 0.005 ± 0.0009 | 0.014 ± 0.0024 | 0.0072 | 0.0060 |
IMCL (%) | 0.004 ± 0.0004 | 0.006 ± 0.0004 | 0.0003 | 0.0001 |
EMCL (%) | 0.009 ± 0.001 | 0.012 ± 0.002 | 0.0895 | 0.1072 |
Abbreviations: ANOVA, analysis of variance; BMI, body mass index; EMCL, extramyocellular lipids; HOMA-IR, homeostasis model assessment-estimated insulin resistance; IHL, intrahepatic lipid; IMCL, intramyocellular lipid; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.
One-way/two-way ANOVA.